Dr. Kruse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-636-2598Fax+1 216-444-9464
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2014 - 2017
UPMC Medical EducationResidency, Internal Medicine, 2011 - 2014
Case Western Reserve University School of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2014 - 2026
PA State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Start of enrollment: 2024 Oct 01
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- 47 citationsReal-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapyLeticia Varella, Akaolisa Samuel Eziokwu, Xuefei Jia, Megan L. Kruse, Halle C. F. Moore
Breast Cancer Research and Treatment. 2019-03-20 - 5 citationsManagement of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.Megan L. Kruse, Irene M. Kang, Nusayba Bagegni, W. Todd Howell, Halle C. F. Moore
Oncology and Therapy. 2021-11-20 - 8 citationsAdrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancerMegan L. Kruse, Mona Patel, Jeffrey M. McManus, Yoon-Mi Chung, Xiuxiu Li
JCI Insight. 2021-10-22
Press Mentions
Cleveland Clinic: First Patient To Receive Breast Cancer Vaccine Shares Health JourneyApril 17th, 2023- First Breast Cancer Vaccine Trial Participant Shares Experience PKGApril 13th, 2023
- Invasive Lobular Carcinoma a Distinctive, Understudied Breast Cancer SubtypeJanuary 5th, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
